| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 28 | 2,125,706 | LQDA, RVMD, ABVX, PCVX | 13F-HR | 8/14/2026 | 000142050626001809 |
| Q1 2026 | 28 | 1,502,765 | LQDA, ABVX, RVMD, PCVX | 13F-HR | 5/15/2026 | 000142050626001039 |
| Q4 2025 | 24 | 1,214,792 | LQDA, ABVX, RVMD, MLYS | 13F-HR | 2/17/2026 | 000142050626000584 |
| Q3 2025 | 18 | 763,509 | LQDA, ABVX, MLYS, EXEL | 13F-HR | 11/14/2025 | 000142050625003441 |
| Q2 2025 | 17 | 520,168 | VRNA, LQDA, EXEL, AGIO | 13F-HR | 8/14/2025 | 000142050625002188 |
| Q1 2025 | 16 | 479,228 | LQDA, VRNA, EXEL, MLYS | 13F-HR | 5/15/2025 | 000142050625001290 |
| Q4 2024 | 14 | 394,876 | LQDA, VRNA, EXEL, EOLS | 13F-HR | 2/14/2025 | 000142050625000624 |
| Q3 2024 | 12 | 315,472 | LQDA, VRNA, EXEL, EOLS | 13F-HR | 11/14/2024 | 000142050624002574 |
| Q2 2024 | 13 | 427,996 | LQDA, ALIM, ANIK, EXEL | 13F-HR | 8/14/2024 | 000181455424000010 |
| Q1 2024 | 12 | 378,314 | LQDA, ALIM, ANIK, EOLS | 13F-HR | 5/13/2024 | 000172749224000006 |
| Q4 2023 | 11 | 296,522 | LQDA, ALIM, ANIK, EXEL | 13F-HR | 2/14/2024 | 000172749224000002 |
| Q3 2023 | 13 | 217,755 | LQDA, ALIM, INTERCEPT PHARMACEUTICALS INC puts, LAB | 13F-HR | 11/14/2023 | 000172749223000011 |
| Q2 2023 | 13 | 177,813 | LQDA, ANIK, EXEL, LAB | 13F-HR | 8/14/2023 | 000172749223000009 |
| Q1 2023 | 11 | 143,374 | LQDA, ANIK, LAB, EXEL | 13F-HR | 5/15/2023 | 000181455423000002 |
| Q4 2022 | 11 | 120,160 | LQDA, ANIK, EOLS, ADMA | RESTATEMENT | 5/15/2023 | 000181455423000005 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Anika Therapeutics, Inc.
13D/A
ANIK · 035255108
|
10.0% |
1/27/2026
Event 1/23/2026
|
|||
| Caligan Partners LP | 10.0% | ||||
| David Johnson | 10.0% | ||||
|
Verrica Pharmaceuticals Inc.
13D/A
VRCA · 92511W207
|
10.0% |
12/30/2025
Event 12/26/2025
|
|||
| Caligan Partners LP | 10.0% | ||||
| David Johnson | 10.0% | ||||
9 other securities where the latest filing is a 13G, the newest filed 8/14/2026. View all